Abstract
The efficacy and safety of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections was evaluated in 72 patients suffering from upper urinary tract infection (19 patients), deep soft tissue infection (16), chronic osteomyelitis (12), abscess (7), chronic otitis media (6), otitis extema (3) and bronchopneumonia (9). Forty-eight patients received an oral dose of 500 mg or 750 mg b.i.d. and five patients an i.v. dose of 200 mg b.i.d., while 19 patients were given both oral and parenteral doses. The duration of therapy ranged from seven days to more than four months. The MICs of ciprofloxacin for the Pseudomonas aeruginosa strains isolated were in the range 0.06–2 mg/1; 36% of the strains were resistant to all other available antibiotics. At follow-up after a minimum of six months the clinical success rate was 75% and the infecting organism was permanently eradicated in 49% of the patients. In nine patients the organism developed resistance, particularly when the initial MIC was higher than 0.5 mg/I. No significant adverse reactions were observed. Ciprofloxacin is the first antipseudomonal antimicrobial agent which can be administered orally and therefore fulfills a need in chemotherapy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Barry, A. L., Jones, R. N., Thornsberry, C., Ayers, L. W., Gerlach, E. H., Sommers, H. M.: Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin and nalidixic acid. Antimicrobial Agents and Chemotherapy 1984, 25: 633 - 637.
Wise, R., Andrews, J. M., Edwards, L. J.: In vitro activity of Bay-O 9867, a new quinolone derivative, compared with that of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559 - 564.
Ridgway, G. L., Mumtar, G., Gabriel, F. G., Oriel, J. D.: The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and mycoplasmas in vitro. European Journal of Clinical Microbiology 1984, 3: 344 - 346.
Wise, R., Lockley, R. M., Webberly, M., Dent, J.: Pharmacokinetics of intravenously administered ciprofloxacin. Antimicrobial Agents and Chemotherapy 1984, 26: 208 - 210.
Giamarellou, H., Galanakis, N., Douzinas, E., Petrikkos, G., El Messidi, M., Papoulias, G., Daikos, G. K.: Evaluation of aztreonam in difficult to treat infections with prolonged post-treatment follow-up. Antimicrobial Agents and Chemotherapy 1984, 26: 245 - 249.
Pancoast, S. J., Prince, A. S., Francke, E. L., Neu, H. C.: Clinical evaluation of piperacillin therapy for infection. Archives of Internal Medicine 1981, 141: 1447 - 1450.
Olive, S., Mogabgab, W. J., Holmes, B., Pollock, B., Pauling, B., Beville, R.: Treatment of serious pseudomonas infections with azlocillin. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement: 153158.
Daikos, G. K., Kosmidis, J., Stathakis, C., Giamarellou, H., Douzinas, E., Kastanakis, S., Papathanassiou, B.: Ceftazidime: therapeutic results in various infections and kinetic studies. Journal of Antimicrobial Chemotherapy 1981, 8, Supplement B: 331-337.
Winston, D. J., Kurtz, T. O., Young, L. S., Busuttil, R. W.: Moxalactam for treatment of nosocomial infections. Reviews of Infectious Diseases 1982, 4, Supplement: 650-655.
Giamarellou, H., Koumaditis, A., Dispiraki, K., Xefteri, H., Daikos, G. K.: Therapeutic effectiveness and pharmacokinetics of cefsulodin in multiresistant Pseudomonas aeruginosa infections. Drugs under Experimental and Clinical Research 1981, 7: 219 - 226.
Giamarellou, H., Efstratiou, A., Tsagarakis, J., Petrikkos, G., Daikos, G. K.: Experience with ciprofloxacin in vitro and in vivo. Arzneimittel Forschung 1984, 12: 1775 - 1778.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1986 Springer Fachmedien Wiesbaden
About this chapter
Cite this chapter
Giamarellou, H., Galanakis, N., Dendrinos, C., Stefanou, J., Daphnis, E., Daikos, G.K. (1986). Evaluation of Ciprofloxacin in the Treatment of Pseudomonas aeruginosa Infections. In: Neu, H.C., Reeves, D.S. (eds) Ciprofloxacin. Current Topics in Infectious Diseases and Clinical Microbiology, vol 1. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-663-01930-5_30
Download citation
DOI: https://doi.org/10.1007/978-3-663-01930-5_30
Publisher Name: Vieweg+Teubner Verlag, Wiesbaden
Print ISBN: 978-3-663-01931-2
Online ISBN: 978-3-663-01930-5
eBook Packages: Springer Book Archive